Sovereign Health Pathways An Australian Model for Essential Medicines Procurement Regional Application: Southeast Asia, Oceania, and Papua New Guinea
The WHO Essential Medicines List exists because health is recognised internationally as the foundation upon which all other development rests. When communities are free from preventable parasitic disease, infectious illness, and treatable conditions, they can pursue education, economic participation, and self-determination. Australia has developed a system that delivers these essential medicines efficiently to some of the most remote communities on Earth. This is not a theoretical proposition—it is a working model, refined over decades, that achieves near-commodity pricing for off-patent medicines while maintaining quality assurance and community-controlled distribution. Sharing this expertise with partner nations across Southeast Asia, Oceania, and Papua New Guinea is an expression of regional solidarity—and a recognition that sustainable health systems benefit everyone, including the pharmaceutical industry whose innovative products require fiscally viable health budgets to reach patients.
Authors
- John R. Smith
- HATI
Institutions
- Capgemini (Netherlands) (NL)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-01-12
- DOI
- https://doi.org/10.5281/zenodo.18217215
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00